T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$1.66B |
| 2 |
Canadian Natural Resources
CNQ
|
+$759M |
| 3 |
Becton Dickinson
BDX
|
+$735M |
| 4 |
Ashland
ASH
|
+$669M |
| 5 |
Keysight
KEYS
|
+$573M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RTX Corp
RTX
|
+$1.73B |
| 2 |
Ecolab
ECL
|
+$1.17B |
| 3 |
Crown Castle
CCI
|
+$906M |
| 4 |
Phillips 66
PSX
|
+$775M |
| 5 |
Gilead Sciences
GILD
|
+$756M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.84% |
| 2 | Consumer Discretionary | 13.93% |
| 3 | Financials | 13.41% |
| 4 | Industrials | 12.4% |
| 5 | Technology | 9.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
676
Cognex
CGNX
$10.2B
| $80.9M | 0.02% |
3,915,866
-2,154,392
| -35% | -$42.9M |
|
677
Post Holdings
POST
$3.65B
| $80.7M | 0.02% |
2,942,445
-687,508
| -19% | -$17M |
|
|
HSNI
678
DELISTED
HSN, Inc.
HSNI
| $80.6M | 0.02% |
1,060,314
-203,260
| -16% | -$14.1M |
|
|
BV
679
DELISTED
Bazaarvoice, Inc.
BV
| $79.6M | 0.02% |
9,902,216
-873,819
| -8% | -$6.5M |
|
680
Artisan Partners
APAM
$2.97B
| $79.6M | 0.02% |
1,575,230
+3,970
| +0.3% | +$198K |
|
681
Healthcare Services Group
HCSG
$1.43B
| $79.2M | 0.02% |
2,560,252
-948
| -0% | -$28.1K |
|
682
NextEra Energy
NEE
$179B
| $78.5M | 0.02% |
2,953,652
+39,396
| +1% | +$995K |
|
|
SPTN
683
DELISTED
SpartanNash
SPTN
| $78.4M | 0.02% |
2,999,350
-23,600
| -0.8% | -$544K |
|
684
Madison Square Garden
MSGS
$9.97B
| $78.4M | 0.02% |
1,459,785
-937,653
| -39% | -$47.2M |
|
685
Sempra
SRE
$56.2B
| $78.3M | 0.02% |
1,406,936
+14,868
| +1% | +$810K |
|
686
Credicorp
BAP
$29.6B
| $78.2M | 0.02% |
488,299
-9,675
| -2% | -$1.54M |
|
|
PDCE
687
DELISTED
PDC Energy, Inc.
PDCE
| $78.1M | 0.02% |
1,892,274
+36,160
| +2% | +$1.46M |
|
|
FNSR
688
DELISTED
Finisar Corp
FNSR
| $78M | 0.02% |
4,019,088
+1,090,961
| +37% | +$18.7M |
|
689
Eagle Materials
EXP
$6.47B
| $77.7M | 0.02% |
1,022,005
+166,640
| +19% | +$14.1M |
|
690
QuidelOrtho
QDEL
$1.02B
| $77.2M | 0.02% |
2,668,790
-6,500
| -0.2% | -$176K |
|
691
Advanced Energy
AEIS
$13.5B
| $77.1M | 0.02% |
3,253,310
-18,600
| -0.6% | -$379K |
|
692
Dominion Energy
D
$59.8B
| $76.6M | 0.02% |
995,485
+25,530
| +3% | +$1.85M |
|
693
Carpenter Technology
CRS
$26.3B
| $76.4M | 0.02% |
1,550,515
-684,730
| -31% | -$33M |
|
694
Southern Company
SO
$106B
| $76.3M | 0.02% |
1,553,832
+47,740
| +3% | +$2.25M |
|
695
Compañía de Minas Buenaventura
BVN
$8.79B
| $76.2M | 0.02% |
7,974,078
+2,747,240
| +53% | +$27.8M |
|
696
HUB Group
HUBG
$2.46B
| $76M | 0.02% |
3,989,320
+91,400
| +2% | +$1.7M |
|
697
Fortinet
FTNT
$118B
| $75.6M | 0.02% |
12,331,925
-201,025
| -2% | -$1.08M |
|
698
Mativ Holdings
MATV
$690M
| $75.6M | 0.02% |
1,787,339
+263,378
| +17% | +$10.9M |
|
|
ATRI
699
DELISTED
Atrion Corp
ATRI
| $75.6M | 0.02% |
222,268
+8,185
| +4% | +$2.66M |
|
|
CLD
700
DELISTED
Cloud Peak Energy Inc
CLD
| $75.6M | 0.02% |
8,230,452
+79,711
| +1% | +$885K |
|
Similar funds
T. Rowe Price Associates's Q4 2014 Portfolio in Review
As of Q4 2014, T. Rowe Price Associates held 2,627 positions worth $471B, up 2.8% from $458B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
T. Rowe Price Associates's Q4 2014 filing shows 87 new, 929 increased, 999 reduced and 89 closed positions. Its largest new stake was Keysight: 17,553,953 shares worth $593M. The largest sale was RTX Corp, an estimated $1.73B.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q4 2014 buy was Keysight: 17,553,953 shares worth $593M.
- T. Rowe Price Associates added most to Allergan plc in Q4 2014, an estimated $1.66B increase.
- T. Rowe Price Associates's biggest Q4 2014 reduction was RTX Corp, cutting an estimated $1.73B.
- T. Rowe Price Associates fully exited ATHLON ENERGY INC COM in Q4 2014, selling an estimated $499M.
- T. Rowe Price Associates's ten largest holdings make up 13% of its $471B portfolio in Q4 2014.
- T. Rowe Price Associates opened 87 new positions and closed 89 in Q4 2014.
- T. Rowe Price Associates's portfolio value rose 2.8% quarter-over-quarter to $471B.
Based on T. Rowe Price Associates's 13F filing for Q4 2014, filed 13 Feb 2015.